| Financial Year |
March 31 2023 |
| Monetary Funds |
5,023,688,726.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,909,452,319.12 |
| Accounts Receivable |
399,181,567.65 |
| Advances to Suppliers |
40,877,340.25 |
| Other Receivables |
101,559,726.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
353,021,393.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
74,193,411.85 |
| Total Current Assets |
8,901,974,484.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
743,729,782.47 |
| Investment Properties |
-- |
| Fixed Assetes |
6,898,816,877.98 |
| Under-construction Projects |
7,931,221,848.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,604,406,790.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,838,520.22 |
| Deferred Income Tax Assets |
558,851,441.10 |
| Other Non-Current Assets |
1,484,346,131.11 |
| Sub-Total of Non-Current Assets |
22,728,987,272.84 |
| Total Assets |
31,630,961,757.62 |
| Short-Term Loans |
1,995,745,966.65 |
| Trading Financial liabilities |
-- |
| Notes Payable |
694,104,130.57 |
| Accounts Payable |
2,474,300,597.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
446,872,887.79 |
| Taxes Payable |
193,143,703.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
492,532,657.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,155,788,170.99 |
| Other Current Liabilities |
111,972,210.82 |
| Sub-Total of Current Liabilities |
8,817,100,945.32 |
| Long-term Loans |
3,841,228,519.86 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,657,069,324.91 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
44,897,214.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,609,164,842.42 |
| Total Liabilities |
18,426,265,787.74 |
| Paid-In Capital(Or Share Stock) |
2,146,624,894.00 |
| Capital Surplus |
4,796,816,534.61 |
| Surplus Reserve |
1,073,890,156.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,174,671,758.09 |
| Minority Stockholder's Interest |
1,109,866,043.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,094,829,925.97 |
| Owner's Equity（Stockholder's Equity） |
13,204,695,969.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,630,961,757.62 |
